Mutations in SETD2 (both mono- and bi-allelic) have been found in many cancer types, including clear cell renal cell carcinoma (ccRCC), gliomas, and in several types of leukemia [116, 172, 203]. Here, SETD2 is linked to nonpapillary renal cell carcinoma.